Local injection with AAV of sh-TRAF1 around the subcutaneous implantation site in sunitinib-resistant CDX mice could significantly restore the sensitivity of RCC cells to sunitinib treatment. This evidence concerns the gene TRAF1 and renal cell carcinoma.